NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding NextCure, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 71 | 1 | 71 | +1 |
| Shares | 14.7M | 38.7K | 14.4M | −339.0K (−2.3%) |
| Value | $99.5M | $261.0K | $86.2M | −$13.0M (−13.1%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held NextCure, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 755,996 | $4.54M | 0.07% |
| Long Focus Capital Management, LLC | 225,000 | $1.35M | 0.37% |
| Sio Capital Management, LLC | 130,000 | $780.0K | 0.24% |
| Assenagon Asset Management S.A. | 125,854 | $755.0K | 0.00% |
| Anson Funds Management LP | 115,328 | $692.0K | 0.10% |
| Atom Investors LP | 43,139 | $259.0K | 0.07% |
| Franklin Resources Inc | 35,500 | $213.0K | 0.00% |
| Minerva Advisors LLC | 31,713 | $190.0K | 0.11% |
| Group One Trading, L.P. | 19,253 | $116.0K | 0.00% |
| Marquette Asset Management, LLC | 17,500 | $105.0K | 0.02% |
| Jump Financial, LLC | 13,700 | $82.0K | 0.01% |
| Charles Schwab Investment Management Inc | 10,000 | $60.0K | 0.00% |
| Quantbot Technologies LP | 3,900 | $23.0K | 0.00% |
| High Net Worth Advisory Group LLC | 500 | $3.00K | 0.00% |
| Simplex Trading, LLC | 335 | $2.00K | 0.00% |
Sold out (14)
Institutions that held NextCure, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Canaan Partners X LLC | 321,647 | $2.17M |
| Tang Capital Management LLC | 300,000 | $2.02M |
| Lion Point Capital, LP | 300,000 | $2.02M |
| Highland Capital Management Fund Advisors, L.P. | 217,139 | $1.46M |
| Diametric Capital, LP | 76,162 | $513.0K |
| Ergoteles LLC | 71,900 | $485.0K |
| SG Americas Securities, LLC | 47,505 | $320.0K |
| HRT Financial LP | 35,126 | $236.0K |
| PDT Partners, LLC | 22,983 | $155.0K |
| D. E. Shaw & Co., Inc. | 12,776 | $86.0K |
| Occudo Quantitative Strategies LP | 12,317 | $83.0K |
| Penserra Capital Management LLC | 630 | $4.00K |
| Liberty Wealth Management LLC | 200 | $1.00K |
| Point72 Hong Kong Ltd | 11 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held NextCure, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 38,719 | $261.0K |